Skip to content

Study held to see the effect of intake of nagbala milk decoction in treatment of high blood pressure

Single arm clinical study to evaluate the effect of nagbala kshirpak in management of essential hypertension

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/028833
Enrollment
40
Registered
2020-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Nagbala kshirpak Dose 40 ml Frequency Twice daily Route of administration Oral Duration of therapy For 21 days: Nagbala churna 5 gm Boiled with 40 ml of cow milk along with 160 ml wate

Sponsors

Samkit Shah
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Systolic Blood Pressure: less than 170 mm of Hg more than or equal to 140 mm of Hg. 2)Diastolic Blood Pressure: less than or equal to 110 mm of Hg or More than 90 mm of Hg. 3)Patient willing to enroll in the research & to sign the consent form

Exclusion criteria

Exclusion criteria: 1)Patient who have past history of atrial fibrillation, acute coronary syndrome, myocardial infarction, stroke or right ventricular hypertrophy, left ventricular hypertrophy, severe arrhythmia in last 6 months. 2)Symptomatic patients with clinical features of early heart failure. 3)Secondary hypertension. 4)Women who are pregnant and lactating or on estrogen replacement therapy. 5)Alcoholics and drug abusers. 6)Accelerated and malignant hypertension.

Design outcomes

Primary

MeasureTime frame
Nagbala kshirpaka is effective in the management of essential hypertension. Timepoint: 21 days study with 3 follow ups (0,7,14,21 days)

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactSamkit Shah

Dr D Y Patil College Of Ayurveda And Research Center

gunvantayurved@gmail.com9028321955

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026